Dr. Hejmadi completed her PhD in radiation oncology, studying the biochemical basis of thermotolerance in murine tumours in vivo. Her postdoctoral research on the anti-tumour effects of novel bioreductive drugs in radio and chemotherapy in murine tumours, has led to the drug currently undergoing Phase II clinical trials. Currently, her research interests are in hypoxia signalling pathways in neuronal and cancer models in vitro. She has been teaching cancer biology to undergraduate students at Bath for the past 10 years and has won several awards for her teaching. She has created novel interactive Flash e-resources on this topic, which will soon be part of a UK HEA Open Educational Resources database.